This revolution is being powered by RNA technology—and Canada is uniquely positioned to lead it. While the swift development ...

A combination messenger RNA vaccine against COVID-19 and seasonal influenza stacked up well against currently recommended vaccines in a phase 3 trial, according to findings published in JAMA.

With a longtime vaccine skeptic serving as the country’s top health official, the movement is likely to make further inroads.

Scientists project that by 2026 the results of clinical trials being conducted in 25 countries, including Spain, will be ...

A combination messenger RNA vaccine against COVID-19 and seasonal influenza stacked up well against currently recommended vaccines in a phase 3 trial, according to findings published in JAMA.

A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators want to see data on whether the new vaccine protects people from getting ...

The company’s shot has been available under emergency use authorization and is the only vaccine that uses a more traditional protein base instead of messenger RNA — an appealing option to some ...

This revolution is being powered by RNA technology — and Canada is uniquely positioned to lead it. While the swift development of COVID-19 vaccines appeared to be a sudden scientific triumph ...

This revolution is being powered by RNA technology — and Canada is uniquely positioned to lead it. While the swift development of COVID-19 vaccines appeared to be a sudden scientific triumph, it was ...